Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
<p>Abstract</p> <p>Introduction</p> <p>Peripartum cardiomyopathy is a rare form of cardiomyopathy, with heterogeneous presentation occurring in women between one-month antepartum and six months postpartum. It carries a poor prognosis and a high risk of mortality.</p&...
Main Authors: | Drexler Helmut, Sliwa Karen, Podewski Edith, Labidi Saida, Meyer Gerd, Hilfiker-Kleiner Denise |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/4/1/80 |
Similar Items
-
Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
by: Rebecca Simon, et al.
Published: (2018-10-01) -
Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
by: Sandeep Chopra, et al.
Published: (2012-01-01) -
Peripartum Cardiomyopathy Presenting with Predominant Left Ventricular Diastolic Dysfunction: Efficacy of Bromocriptine
by: Piercarlo Ballo, et al.
Published: (2012-01-01) -
Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report
by: Saya Hakata, et al.
Published: (2019-06-01) -
Clinical profi ling of patients with peripartum cardiomyopathy and its value for translational research
by: Olaf Forster, et al.
Published: (2017-04-01)